Long-term codeine use is associated with depressive symptoms

Journal of Clinical Psychopharmacology

Volumn 19, Issue 4, 1999, Pages 373-376

  Romach, Myroslava K ^a,b   Sproule, Beth A ^a   Sellers, Edward M ^a   Somer, Gail ^a   Busto, Usoa E ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; PARACETAMOL;

ADULT; ARTICLE; DEPRESSION; DRUG ABUSE; DYSPHORIA; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MOOD; OPIATE ADDICTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CODEINE; DEPRESSION; FEMALE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; ONTARIO; OPIOID-RELATED DISORDERS; PSYCHIATRIC STATUS RATING SCALES;

EID: 0032782187     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199908000-00015     Document Type: Article

References (16)

1. Weppner RS. "Cheap kicks": codeine cough syrup abusers and some of their social characteristics. Int J Addict 1971;6:647-60.
2. IMS Canada Report. Top 200 drugs of 1996. Pharm Pract 1996; 12:67-79.
3. Himmelsbach CK. Part I. A review of the literature on codeine addiction. Public Health Rep 1940;158:1-10.
4. Isaac P, Seto W, Lanctot K, Busto UE. Use and abuse of prescription opioids in Canada 1978 to 1989. Can J Clin Pharmacol 1995;2:81-6.
5. International Narcotics Control Board. Narcotic drugs: estimated world requirements for 1991, statistics for 1989. Vienna: International Narcotics Control Board, 1991:118.
6. Caraco Y, Sheller J, Wood AJJ. Pharmacogenetic determinations of the effects of codeine and prediction of drug interactions. J Pharmacol Exp Ther 1997;278:1165-74.
7. Tyndale RF, Droll KP, Sellers EM. Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. Pharmacogenetics 1997;7:375-9.
8. Annis HM, Martin G. Inventory of drug taking situations. Toronto: Addiction Research Foundation of Ontario, 1985.
9. Derogatis LR. SCL-90-R: administration, scoring and procedures manual-II for the revised version. Towson, MD: Clinical Psychometrics Research, 1983.
10. Sproule BA, Busto UE, Somer G, Romach MK, Sellers EM. Characteristics of dependent and nondependent regular users of codeine. J Clin Psychopharmacol 1999;19:367-72.
11. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 1985;142:1259-64.
12. Krystal H, Raskin HA. Drug dependence: aspects of ego functions. Detroit: Wayne State University Press, 1970.
13. Carmody TP. Affect regulation, nicotine addiction and smoking cessation. J Psychoactive Drugs 1989;21:331-42.
14. Unruth AM. Gender variations in clinical pain experience. Pain 1996;65:123-67.
15. Kadden RM, Kranzler HR, Rounsaville BJ. Validity of the distinction between "substance-induced" and "independent" depression and anxiety disorders. Am J Addict 1995;4:107-17.
16. Romach MK, Somer GR, Sobell LC, Sobell MB, Sellers EM. Characteristics of long-term alprazolam users in the community. J Clin Psychopharmacol 1992;12:316-21.